➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Merck
McKesson
Baxter
Mallinckrodt

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Details for Patent: 9,839,626

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,839,626
Title:Duloxetine sprinkles
Abstract: The present invention relates in part a to multiparticulate sprinkle dosage form comprising duloxetine or a pharmaceutically acceptable salt thereof, having higher acid resistance as compared to commercially available delayed release formulations. It further relates to various methods of administering the said multiparticulate sprinkle dosage forms.
Inventor(s): Agarwal; Ravindra (Udaipur, IN), Singhal; Tarun (Bharatpur, IN), Kochhar; Ravi (Gurgaon, IN)
Assignee:
Application Number:15/486,670
Patent Claim Types:
see list of patent claims
Formulation; Compound; Device; Dosage form;

Drugs Protected by US Patent 9,839,626

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sun Pharma Global DRIZALMA SPRINKLE duloxetine hydrochloride CAPSULE, DELAYED RELEASE;ORAL 212516-001 Jul 19, 2019 RX Yes No   Start Trial   Start Trial Y   Start Trial
Sun Pharma Global DRIZALMA SPRINKLE duloxetine hydrochloride CAPSULE, DELAYED RELEASE;ORAL 212516-002 Jul 19, 2019 RX Yes No   Start Trial   Start Trial Y   Start Trial
Sun Pharma Global DRIZALMA SPRINKLE duloxetine hydrochloride CAPSULE, DELAYED RELEASE;ORAL 212516-003 Jul 19, 2019 RX Yes No   Start Trial   Start Trial Y   Start Trial
Sun Pharma Global DRIZALMA SPRINKLE duloxetine hydrochloride CAPSULE, DELAYED RELEASE;ORAL 212516-004 Jul 19, 2019 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,839,626

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
India201611042630Dec 14, 2016

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Colorcon
Boehringer Ingelheim
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.